Literature DB >> 2960514

The protective effect of acylation on the stability of anisoylated plasminogen streptokinase activator complex in human plasma.

R Fears1, H Ferres, R Standring.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2960514     DOI： 10.2165/00003495-198700333-00007

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  8 in total

1.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

Review 2.  Thrombolytic therapy in the eighties.

Authors:  M Verstraete; D Collen
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

3.  Induction of a sustained fibrinolytic response by BRL 26921 in vitro.

Authors:  R Fears; J Green; R A Smith; P Walker
Journal:  Thromb Res       Date:  1985-05-01       Impact factor: 3.944

4.  Assessment of anti-streptokinase antibody levels in human sera using a microradioimmunoassay procedure.

Authors:  D M Moran; R Standring; E A Lavender; G S Harris
Journal:  Thromb Haemost       Date:  1984-12-29       Impact factor: 5.249

5.  Isolation of a human tissue-type plasminogen-activator genomic DNA clone and its expression in mouse L cells.

Authors:  M J Browne; A W Tyrrell; C G Chapman; J E Carey; D M Glover; F G Grosveld; I Dodd; J H Robinson
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction.

Authors:  M Been; D P de Bono; A L Muir; F E Boulton; R Fears; R Standring; H Ferres
Journal:  Int J Cardiol       Date:  1986-04       Impact factor: 4.164

7.  Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.

Authors:  S L Gonias; M Einarsson; S V Pizzo
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

8.  High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: description of effects in the circulation.

Authors:  R L Mentzer; A Z Budzynski; S Sherry
Journal:  Am J Cardiol       Date:  1986-06-01       Impact factor: 2.778
  8 in total
  3 in total

Review 1.  Prodrugs.

Authors:  D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

2.  The effect of heparin and fibrin on the enzymatic efficiencies of thrombolytics in vitro.

Authors:  R Fears
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.

Authors:  H Ferres
Journal:  Drugs       Date:  1987       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.